Related Experiment Video

Updated: Mar 14, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling

Shubin Hong1, Shuang Yu1, Jin Li2

  • 11 Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, China .

Thyroid : Official Journal of the American Thyroid Association
|October 9, 2016
PubMed
Abstract

Insights

MicroRNA-20b (miR-20b) acts as a tumor suppressor in papillary thyroid carcinoma (PTC). Upregulating miR-20b inhibits PTC cell growth, migration, and invasion by targeting SOS1 and ERK2, suggesting its therapeutic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of biological processes.
  • MiR-20b dysregulation is observed in papillary thyroid carcinoma (PTC).
  • The specific functions of miR-20b in PTC remain largely unelucidated.

Purpose of the Study:

  • To investigate the biological functions of miR-20b in PTC.
  • To elucidate the molecular mechanisms underlying miR-20b's role in PTC.
  • To assess miR-20b as a potential therapeutic target for PTC.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for miR-20b expression analysis in PTC tissues and cell lines.
  • In vitro assays to evaluate the effects of miR-20b on cell viability, migration, and invasion.
  • Bioinformatic analysis and experimental validation to identify miR-20b targets and signaling pathways.
  • In vivo studies using xenograft models to assess miR-20b's impact on tumor growth.

Main Results:

  • MiR-20b was significantly downregulated in PTC tissues and correlated with lymph node metastasis and advanced TNM stage.
  • Overexpression of miR-20b suppressed PTC cell viability, migration, and invasion.
  • MiR-20b directly targets Son of Sevenless homolog 1 (SOS1) and Extracellular Signal-Regulated Kinase 2 (ERK2), inhibiting the MAPK/ERK signaling pathway.
  • MiR-20b overexpression suppressed tumor growth in a xenograft mouse model.

Conclusions:

  • MiR-20b exhibits tumor-suppressor functions in PTC.
  • MiR-20b inhibits PTC progression and metastasis by targeting SOS1 and ERK2 within the MAPK/ERK pathway.
  • MiR-20b represents a promising therapeutic target for PTC treatment.
Keywords:
MAPK/ERK signaling pathwaycell viabilityinvasionmiR-20bpapillary thyroid carcinoma

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.7K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K